Experimental cholesterol pill cuts heart attack risk with ‘convenient’ once-daily dose
A new daily pill could provide an easier, more convenient way to lower cholesterol and reduce heart attack and stroke risk. The experimental medication, called Obicetrapib, underwent a Phase 3 clinical trial at Monash University in Australia. The trial included more than 2,500 people averaging 65 years of age. All had either been diagnosed with…

